{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:06:02Z","timestamp":1790255162505,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021550","name":"Chittaranjan National Cancer Institute","doi-asserted-by":"publisher","award":["CNCI-IEC-SB-2022-34"],"award-info":[{"award-number":["CNCI-IEC-SB-2022-34"]}],"id":[{"id":"10.13039\/501100021550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021550","name":"Chittaranjan National Cancer Institute","doi-asserted-by":"publisher","award":["08"],"award-info":[{"award-number":["08"]}],"id":[{"id":"10.13039\/501100021550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021550","name":"Chittaranjan National Cancer Institute","doi-asserted-by":"publisher","award":["IAEC-1774\/SBn-6\/2021\/11"],"award-info":[{"award-number":["IAEC-1774\/SBn-6\/2021\/11"]}],"id":[{"id":"10.13039\/501100021550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021550","name":"Chittaranjan National Cancer Institute","doi-asserted-by":"publisher","award":["IAEC\/2024\/62 Renew-0\/Sr"],"award-info":[{"award-number":["IAEC\/2024\/62 Renew-0\/Sr"]}],"id":[{"id":"10.13039\/501100021550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/2\/2\/63\/2022-NCD-III"],"award-info":[{"award-number":["3\/2\/2\/63\/2022-NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRPSG-2025-01-06315"],"award-info":[{"award-number":["IIRPSG-2025-01-06315"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/21\/2022\/NCD-III"],"award-info":[{"award-number":["5\/13\/21\/2022\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001410","name":"CSIR - Human Resource Development Group","doi-asserted-by":"publisher","award":["112-1831-6176\/2K23\/1"],"award-info":[{"award-number":["112-1831-6176\/2K23\/1"]}],"id":[{"id":"10.13039\/501100001410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010422","name":"Israel Atomic Energy Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["191620061322"],"award-info":[{"award-number":["191620061322"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omton.2026.201250","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:12:33Z","timestamp":1779981153000},"page":"201250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Atorvastatin pre-exposure in hypercholesterolemia remedies 27HC mediated dendritic cell dysfunctions in triple-negative breast cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Pritha Roy","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohona","family":"Chakravarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurav","family":"Bera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muqtada Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushikesh","family":"Biradar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanya","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indranil","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjan","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Lasure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhina","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prodipto","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhendu","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neyaz","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathindranath","family":"Baral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saptak","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2241-2033","authenticated-orcid":false,"given":"Anamika","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201250_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: Pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"NPJ breast cancer"},{"key":"10.1016\/j.omton.2026.201250_bib2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41467-024-45160-y","article-title":"The anti-PD-L1\/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201250_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.omton.2026.201250_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201250_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41416-025-03070-w","article-title":"Statin use and breast cancer-specific mortality and recurrence: a systematic review and meta-analysis including the role of immortal time bias and tumour characteristics","volume":"133","author":"Scott","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omton.2026.201250_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10549-023-06917-z","article-title":"Cholesterol and breast cancer risk: a cohort study using health insurance claims and health checkup databases","volume":"199","author":"Narii","year":"2023","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.omton.2026.201250_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrcardio.2013.80","article-title":"Statins in the primary prevention of cardiovascular disease","volume":"10","author":"Reiner","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.omton.2026.201250_bib8","first-page":"6","article-title":"Statins outperform dietary supplements for LDL-C lowering","volume":"20","author":"Lim","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.omton.2026.201250_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12986-024-00811-1","article-title":"The effect of hyperlipidemia on overall survival in patients with cancer was differentiated by BMI and hyperlipidemia type","volume":"21","author":"Tian","year":"2024","journal-title":"Nutr Metab (Lond) ."},{"key":"10.1016\/j.omton.2026.201250_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12944-023-01997-8","article-title":"Dyslipidemia: prevalence and association with precancerous and cancerous lesions of the cervix; a pilot study","volume":"23","author":"Mwangi","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.omton.2026.201250_bib11","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41416-021-01529-0","article-title":"Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer","volume":"125","author":"Marti","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omton.2026.201250_bib12","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1038\/s41598-024-53252-4","article-title":"Long-term use of anti-cholesterol drugs and cancer risks in a Japanese population","volume":"14","author":"Okita","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201250_bib13","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1158\/1078-0432.CCR-20-1967","article-title":"Statins as Anticancer Agents in the Era of Precision Medicine","volume":"26","author":"Longo","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201250_bib14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41391-020-0221-7","article-title":"A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer","volume":"23","author":"Longo","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.omton.2026.201250_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.eururo.2018.06.037","article-title":"Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy\u2014A Randomized, Double-blind, Placebo-controlled Clinical Trial","volume":"74","author":"Murtola","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omton.2026.201250_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10549-013-2473-6","article-title":"Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial","volume":"138","author":"Bjarnadottir","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.omton.2026.201250_bib17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41590-024-02065-8","article-title":"Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer","volume":"26","author":"Belabed","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2026.201250_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.837574","article-title":"Efficient Cholesterol Transport in Dendritic Cells Defines Optimal Exogenous Antigen Presentation and Toxoplasma gondii Proliferation","volume":"10","author":"Croce","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omton.2026.201250_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.omton.2026.201250_bib20","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","article-title":"The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells","volume":"8","author":"Baek","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201250_bib21","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4049\/jimmunol.1302801","article-title":"Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer","volume":"192","author":"Ramakrishnan","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201250_bib22","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab095","article-title":"The Cholesterol Metabolite 27HC Increases Secretion of Extracellular Vesicles Which Promote Breast Cancer Progression","volume":"162","author":"Baek","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.omton.2026.201250_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.canlet.2020.08.020","article-title":"27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression","volume":"493","author":"Ma","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2026.201250_bib24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41569-024-01017-x","article-title":"Cardiovascular disease and cancer: shared risk factors and mechanisms","volume":"21","author":"Wilcox","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.omton.2026.201250_bib25","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.amepre.2025.02.001","article-title":"Statin Use and Cardiovascular Risk in Young Adults in the United States","volume":"68","author":"Kothari","year":"2025","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.omton.2026.201250_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/ph15050579","article-title":"Effects of the Prior Use of Statins on Head and Neck Cancer Risk: A Hospital-Based Case\u2013Control Study","volume":"15","author":"Saka-Herr\u00e1n","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.omton.2026.201250_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ame2.12139","article-title":"Clinical hematological and biochemical parameters in Swiss, BALB\/c, C57BL\/6 and B6D2F1 Mus musculus","volume":"3","author":"Silva-Santana","year":"2020","journal-title":"Anim Model Exp Med"},{"key":"10.1016\/j.omton.2026.201250_bib28","doi-asserted-by":"crossref","first-page":"38378","DOI":"10.1074\/jbc.M105805200","article-title":"27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells","volume":"276","author":"Fu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201250_bib29","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41467-025-58289-1","article-title":"Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse","volume":"16","author":"Heras-Murillo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201250_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13062-023-00430-5","article-title":"Conventional type 1 dendritic cells (cDC1) in cancer immunity","volume":"18","author":"Liu","year":"2023","journal-title":"Biol. Direct"},{"key":"10.1016\/j.omton.2026.201250_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00262-023-03597-y","article-title":"Vaccination against neoantigens induced in cross-priming cDC1 in vivo","volume":"73","author":"Clark","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.omton.2026.201250_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.imlet.2005.11.021","article-title":"Cholesterol and sphingolipids as lipid organizers of the immune cells\u2019 plasma membrane: Their impact on the functions of MHC molecules, effector T-lymphocytes and T-cell death","volume":"104","author":"Gombos","year":"2006","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.omton.2026.201250_bib33","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1641","article-title":"27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen","volume":"13","author":"Umetani","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201250_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-67706-2","article-title":"Atorvastatin lowers breast cancer risk by reversing an early tumorigenic signature","volume":"14","author":"Foda","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201250_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/1940-6207.CAPR-15-0300","article-title":"The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women","volume":"9","author":"Ji","year":"2016","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.omton.2026.201250_bib36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13046-023-02865-0","article-title":"TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages","volume":"42","author":"Huang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201250_bib37","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41598-024-59845-3","article-title":"A high-cholesterol diet promotes the intravasation of breast tumor cells through an LDL\u2013LDLR axis","volume":"14","author":"Magalh\u00e3es","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201250_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41419-023-05687-2","article-title":"TUBB2B facilitates progression of hepatocellular carcinoma by regulating cholesterol metabolism through targeting HNF4A\/CYP27A1","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2026.201250_bib39","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omton.2026.201250_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1530\/ERC-17-0449","article-title":"The impact of 27-hydroxycholesterol on endometrial cancer proliferation","volume":"25","author":"Gibson","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.omton.2026.201250_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2019.03.020","article-title":"Increased production of 27-hydroxycholesterol in human colorectal cancer advanced stage: Possible contribution to cancer cell survival and infiltration","volume":"136","author":"Rossin","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.omton.2026.201250_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2012.07.029","article-title":"HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells","volume":"225","author":"hui","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.omton.2026.201250_bib43","doi-asserted-by":"crossref","first-page":"42664","DOI":"10.1074\/jbc.M112.386045","article-title":"Cholesterol and Sphingomyelin Drive Ligand-independent T-cell Antigen Receptor Nanoclustering","volume":"287","author":"Moln\u00e1r","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201250_bib44","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1073\/pnas.200367697","article-title":"Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR\u03b1","volume":"97","author":"Venkateswaran","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omton.2026.201250_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","article-title":"Cross-priming in cancer immunology and immunotherapy","volume":"25","author":"Luri-Rey","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omton.2026.201250_bib46","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ccell.2023.06.008","article-title":"A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity","volume":"41","author":"Meiser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2026.201250_bib47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1158\/2159-8290.CD-15-0510","article-title":"Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti\u2013PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells","volume":"6","author":"S\u00e1nchez-Paulete","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2026.201250_bib48","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3389\/fimmu.2018.00682","article-title":"Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance Via Antigen-Specific T Regulatory Type 1 Cells","volume":"9","author":"Comi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201250_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00007","article-title":"Regulatory Dendritic Cells for Immunotherapy in Immunologic Diseases","volume":"5","author":"Gordon","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201250_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113866","article-title":"Atypical cofilin signaling drives dendritic cell migration through the extracellular matrix via nuclear deformation","volume":"43","author":"Warner","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2026.201250_bib51","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jcyt.2015.06.002","article-title":"Generation of potent dendritic cells with improved migration ability through p-cofilin and sarco\/endoplasmic reticulum Ca2+ transport ATPase 2 regulation","volume":"17","author":"Choi","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omton.2026.201250_bib52","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201250_bib53","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jss.2017.05.040","article-title":"Transforming growth factor \u03b21 and Fas ligand synergistically enhance immune tolerance in dendritic cells in liver transplantation","volume":"218","author":"Qiu","year":"2017","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.omton.2026.201250_bib54","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"Ido expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omton.2026.201250_bib55","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1172\/JCI21583","article-title":"Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes","volume":"114","author":"Munn","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omton.2026.201250_bib56","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1084\/jem.191.7.1085","article-title":"Notch1 Deficiency Dissociates the Intrathymic Development of Dendritic Cells and T Cells","volume":"191","author":"Radtke","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omton.2026.201250_bib57","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1182\/blood-2003-04-1034","article-title":"Notch signaling is necessary but not sufficient for differentiation of dendritic cells","volume":"102","author":"Cheng","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201250_bib58","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.celrep.2018.05.068","article-title":"Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells","volume":"23","author":"Kirkling","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2026.201250_bib59","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12964-019-0367-x","article-title":"Estrogen receptor \u03b1-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer","volume":"17","author":"Shen","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omton.2026.201250_bib60","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s11033-024-10058-x","article-title":"17\u03b2-estradiol inhibits Notch1 activation in murine macrophage cell line RAW 264.7","volume":"51","author":"Severi","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.omton.2026.201250_bib61","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2016.08.013","article-title":"IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively","volume":"45","author":"Sichien","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2026.201250_bib62","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.4049\/jimmunol.1203541","article-title":"Batf3 and Id2 Have a Synergistic Effect on Irf8 -Directed Classical CD8\u03b1+ Dendritic Cell Development","volume":"191","author":"Jaiswal","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201250_bib63","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ni.1615","article-title":"The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues","volume":"9","author":"Waskow","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2026.201250_bib64","first-page":"356","article-title":"Statins and endocrine resistance in breast cancer","volume":"4","author":"Hyder","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.omton.2026.201250_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1058963","article-title":"Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2","volume":"13","author":"Lellahi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201250_bib66","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1158\/0008-5472.CAN-22-3864","article-title":"Terminally Exhausted CD8+ T Cells Resistant to PD-1 Blockade Promote Generation and Maintenance of Aggressive Cancer Stem Cells","volume":"83","author":"Chakravarti","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201250_bib67","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cmet.2014.05.013","article-title":"The Cholesterol Metabolite 27-Hydroxycholesterol Promotes Atherosclerosis via Proinflammatory Processes Mediated by Estrogen Receptor Alpha","volume":"20","author":"Umetani","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.omton.2026.201250_bib68","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1523\/JNEUROSCI.18-07-02550.1998","article-title":"Estradiol Increases Dendritic Spine Density by Reducing GABA Neurotransmission in Hippocampal Neurons","volume":"18","author":"Murphy","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omton.2026.201250_bib69","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7150\/ijbs.11380","article-title":"Tamoxifen Inhibits ER-negative Breast Cancer Cell Invasion and Metastasis by Accelerating Twist1 Degradation","volume":"11","author":"Ma","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.omton.2026.201250_bib70","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/1541-7786.MCR-23-0993","article-title":"Neem Leaf Glycoprotein Disrupts Exhausted CD8+ T-Cell\u2013Mediated Cancer Stem Cell Aggression","volume":"22","author":"Chakravarti","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.omton.2026.201250_bib71","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12964-024-01576-z","article-title":"Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NF\u03baB","volume":"22","author":"Ganguly","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omton.2026.201250_bib72","first-page":"14","article-title":"High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP","volume":"18","author":"Dhar","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:39:20Z","timestamp":1790253560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926001268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2950329926001268"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201250","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atorvastatin pre-exposure in hypercholesterolemia remedies 27HC mediated dendritic cell dysfunctions in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201250"}}